Daily Target 2X Long MRNA ETF
Daily Target 2X Long MRNA ETF
Your view on MRNX
Overview
What the company does, where it operates, and who runs it.
About Daily Target 2X Long MRNA ETF
- Industry
- Asset Management - Leveraged
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- 78 SW 7th St. 5th Floor, Miami, FL, US
- Industry
- Asset Management - Leveraged
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- 78 SW 7th St. 5th Floor, Miami, FL, US
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Daily Target 2X Long MRNA ETF, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Daily Target 2X Long MRNA ETF. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Daily Target 2X Long MRNA ETF. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Daily Target 2X Long MRNA ETF. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Daily Target 2X Long MRNA ETF. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Daily Target 2X Long MRNA ETF valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Daily Target 2X Long MRNA ETF, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Daily Target 2X Long MRNA ETF executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Daily Target 2X Long MRNA ETF. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Daily Target 2X Long MRNA ETF. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Daily Target 2X Long MRNA ETF. Press releases and market coverage, newest first.